Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mira Pharma

1.17
+0.09008.33%
Post-market: 1.170.00000.00%19:47 EDT
Volume:416.61K
Turnover:473.09K
Market Cap:19.38M
PE:-2.04
High:1.20
Open:1.09
Low:1.07
Close:1.08
Loading ...

Company Profile

Company Name:
Mira Pharma
Exchange:
NASDAQ
Establishment Date:
2020
Employees:
- -
Office Location:
1200 Brickell Avenue,Suite 1950 #1183,Miami,Florida,United States
Zip Code:
32183
Fax:
- -
Introduction:
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.

Directors

Name
Position
Chris Chapman
Executive Chairman and Director
Erez Aminov
Chief Executive Officer and Director
Adam Kaplin
President and Chief Scientific Officer and Director
Christos Nicholoudis
Director and General Counsel
Brad Kroenig
Director
Dave Vorhoff
Director
Hugh McColl III
Director
Talhia Tuck
Director

Shareholders

Name
Position
Erez Aminov
Chief Executive Officer and Director
Michelle Yanez
Chief Financial Officer, Secretary and Treasurer
Adam Kaplin
President and Chief Scientific Officer and Director
Chris Chapman
Executive Chairman and Director
Christos Nicholoudis
Director and General Counsel